Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $53.5 million.

  • Treace Medical Concepts' Non-Current Debt rose 55.98% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 55.98%. This contributed to the annual value of $53.3 million for FY2024, which is 56.22% up from last year.
  • As of Q3 2025, Treace Medical Concepts' Non-Current Debt stood at $53.5 million, which was up 55.98% from $53.5 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Non-Current Debt high stood at $53.5 million for Q3 2025, and its period low was $29.2 million during Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Non-Current Debt value was $52.9 million (recorded in 2023), while the average stood at $46.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first skyrocketed by 7953.34% in 2022, then skyrocketed by 55.87% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Non-Current Debt stood at $29.4 million in 2021, then soared by 79.5% to $52.7 million in 2022, then increased by 0.56% to $53.0 million in 2023, then rose by 0.56% to $53.3 million in 2024, then grew by 0.42% to $53.5 million in 2025.
  • Its last three reported values are $53.5 million in Q3 2025, $53.5 million for Q2 2025, and $53.4 million during Q1 2025.